
### [MONDO:0016542](http://purl.obolibrary.org/obo/MONDO_0016542)
**Label:** immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome

**Subclasses:** [MONDO:0013153](http://purl.obolibrary.org/obo/MONDO_0013153) (inflammatory bowel disease 28), [MONDO:0012941](http://purl.obolibrary.org/obo/MONDO_0012941) (inflammatory bowel disease 25), [MONDO:0014338](http://purl.obolibrary.org/obo/MONDO_0014338) (IL21-related infantile inflammatory bowel disease), 

**Mapped go classes:** [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0005134](http://purl.obolibrary.org/obo/GO_0005134) (interleukin-2 receptor binding), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0032825](http://purl.obolibrary.org/obo/GO_0032825) (positive regulation of natural killer cell differentiation), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045078](http://purl.obolibrary.org/obo/GO_0045078) (positive regulation of interferon-gamma biosynthetic process), [GO:0002757](http://purl.obolibrary.org/obo/GO_0002757) (immune response-activating signal transduction), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0007260](http://purl.obolibrary.org/obo/GO_0007260) (tyrosine phosphorylation of STAT protein), [GO:0048469](http://purl.obolibrary.org/obo/GO_0048469) (cell maturation), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0045579](http://purl.obolibrary.org/obo/GO_0045579) (positive regulation of B cell differentiation), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0005126](http://purl.obolibrary.org/obo/GO_0005126) (cytokine receptor binding), [GO:0045954](http://purl.obolibrary.org/obo/GO_0045954) (positive regulation of natural killer cell mediated cytotoxicity), [GO:0004920](http://purl.obolibrary.org/obo/GO_0004920) (interleukin-10 receptor activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0004904](http://purl.obolibrary.org/obo/GO_0004904) (interferon receptor activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030890](http://purl.obolibrary.org/obo/GO_0030890) (positive regulation of B cell proliferation), [GO:0002729](http://purl.obolibrary.org/obo/GO_0002729) (positive regulation of natural killer cell cytokine production), [GO:0032733](http://purl.obolibrary.org/obo/GO_0032733) (positive regulation of interleukin-10 production), [GO:0001819](http://purl.obolibrary.org/obo/GO_0001819) (positive regulation of cytokine production), [GO:0098508](http://purl.obolibrary.org/obo/GO_0098508) (endothelial to hematopoietic transition), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 53.85%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 53.85%
- Thing 52.31%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 39.20%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 39.20%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 39.20%


